SMARCA4 and neoplasm: Approaches such as miR-423-3p mimics or small molecules that inhibit the ability of GAS5 to sponge miR-423-3p could potentially restore the tumor-suppressive activity of miR-423-3p and reduce SMARCA4 levels, thereby inhibiting HCC growth and progression.